NDA cCep – Drug Price Control in India: A Regulatory Perspective

Posted by By at 1 June, at 15 : 03 PM Print

May 22, 2020 (21:00 – 22:00 IST)

Speakers: Dr. Milind Antani, Gowree Gokhale, Darren Punnen
Kanchana TK- Director- Government affairs, Market Access, Healthcare Affairs, Institutional business Boehringer Ingelheim
MK Narayanswami – former Senior Director – Accounting and Taxation Sanofi India Limited
Currently associated as Consultant to Sanofi India and OPPI

To be our Premium Guest,

Please Register

NDA cCep

Related Posts

Post Your Comment

You must be logged in to post a comment.

About Us

Nishith Desai Associates (NDA) is a research based international law firm with offices in Mumbai, Bangalore, Silicon Valley, Singapore, New Delhi, Munich and New York.


Mobile App